000 01279 a2200337 4500
005 20250517163019.0
264 0 _c20180510
008 201805s 0 0 eng d
022 _a1096-1186
024 7 _a10.1016/j.phrs.2017.07.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPulluri, Bhargavi
245 0 0 _aTumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance.
_h[electronic resource]
260 _bPharmacological research
_cSep 2017
300 _a95-102 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMitogen-Activated Protein Kinase Kinases
_xantagonists & inhibitors
650 0 4 _aProto-Oncogene Proteins B-raf
_xantagonists & inhibitors
650 0 4 _aTumor Microenvironment
700 1 _aKumar, Abhijeet
700 1 _aShaheen, Montaser
700 1 _aJeter, Joanne
700 1 _aSundararajan, Srinath
773 0 _tPharmacological research
_gvol. 123
_gp. 95-102
856 4 0 _uhttps://doi.org/10.1016/j.phrs.2017.07.006
_zAvailable from publisher's website
999 _c27350625
_d27350625